Read through of truncated proteins in premature termination codon diseases using an optimized genetic codon expansion system
AssigneePeking University
InventorsQing Xia, Qi Yang
Life of this patent
Estimating the term…
Loading patent…
AssigneePeking University
InventorsQing Xia, Qi Yang
Estimating the term…
Provided is a method for high-efficiently reading through a nonsense mutation site in a pathogenic gene in a monogenic hereditary disease and restoring the normal structure and function of a mutant protein, by using a genetic code expanded non-natural amino acid system. By modifying a tRNA of Methanosarcina barkeri (tRNAPyl), an all-new UAA and UGA encoded non-natural amino acid system that has high read-through efficiency is obtained, and the range of using the orthogonal pair of tRNAPyl and pyrrolysyl-tRNA synthetase (PylRS) is expanded. A plasmid mimicking the endogenous premature termination codon is constructed, so as to evaluate the efficiency of reading through the endogenous premature termination codon. Also provided is a system mainly comprising pathogenic genes of monogenic hereditary diseases and tumor inhibitory genes in tumor cells.
A method of expressing a full length dystrophin protein in a cell of a muscular dystrophy patient, the cell of the patient comprising a Duchenne muscular dystrophy (DMD) gene that is mutated by the presence of a premature UAA or UGA stop codon, the method comprising introducing into the cell a non-natural amino acid system consisting of a tRNA consisting of SEQ ID NO:
Dependencies are inferred from the claim text.